What is the main business of Equalan Pharma Polska?

The main business activity of Equalan Pharma Polska focuses on agents involved in non-specialised wholesale.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on November 10, 2022.

Where is the headquarters located?

The headquarters is located at: ul. Gen. Władysława Andersa 38A, 15-113 Białystok.

Who is on the management board?

The management board includes Adam Mocarski (President of the Management Board).

What is the share capital?

The share capital of the company is PLN 5,000 (approx. $1,351).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.

What revenue was generated?

In 2024, the company generated total revenue of $579,985, representing a decrease of 24.9% compared to 2023.

Is the company profitable?

No, the company recorded a net loss of $163,987 in 2024. For comparison, in 2023 the loss was $87,426, meaning the company increased its loss by 78.2%.

Which cost dominates operating expenses?

The largest operating cost category falls under employee remuneration. This category amounted to $332,348 in 2024, representing 45% of all operating expenses.

Equalan Pharma Polskasp. z o.o.

Agents involved in the sale of a variety of goods

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2022-11-10

Share capital

5 000,00 PLN

Activity description

Equalan Pharma Polska manufactures cosmetics for face, body and hair care, as well as dietary supplements. The company also provides contract manufacturing of cosmetics and supplements.

Registered address

ul. Gen. Władysława Andersa 38A, 15-113 Białystok, Poland

Website

equalanpharma.eu

Phone

Social media

Financials

The financial statement for 2025 has not yet been filed with the Financial Document Repository (past deadline).

Revenue history (in k)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2024.

Results vs industry

Revenue

This companyUSD 579.98kMedianUSD 125.67kAverageUSD 1.85m

Net profit

This companyUSD -163.99kMedianUSD 3.26kAverageUSD 75.51k

Operating costs

This companyUSD 737.10kMedianUSD 112.42kAverageUSD 1.74m

Assets

This companyUSD 49.29kMedianUSD 92.91kAverageUSD 893.09k

Industry

Bank accounts

Registered as a VAT taxpayer on 2022-11-22. Active

ING Bank Śląski
21 1050 1953 1000 0090 8186 8748
ING Bank Śląski
22 1050 1953 1000 0090 8186 8730

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

No public aid cases recorded in the last 10 years.

Tenders

No recorded participation in tenders.

Authorized Representatives

Adam Mocarski – President of the Management Board

Natalia Iwaniuk – Management Board Member

Manner of representation

Each member of the management board is authorized to make declarations on behalf of the company independently.

Ownership

Owner	Shares	Share value	Stake
Mf Invest Sp. z o.o.	50	$1,350.62	100%

Beneficial owners

Person	Rights

Competitors

Name	Revenue	Website
Annabellasp. z o.o.	$1,518,295.28	annabella.com.pl
Opcja Naturasp. z o.o.	$1,332,155.80	opcjanatura.pl
Vanillasp. z o.o.	$1,177,127.60	vanilla.rzeszow.pl
Ideal Polandsp. z o.o.	$1,092,652.45	ideal-poland.pl
Lakrimsp. z o.o.	$679,888.69	lakrim.pl
Salco Au Naturelsp. z o.o.	$536,005.39	salcoaunaturel.com
Biocomsp. z o.o.	$433,929.05	biocom.net.pl
Beauty Care Solutionsp. z o.o.	$391,209.94	ohhira.pl
S-Editsp. z o.o.	$341,729.07	s-edit.pl
A.I. Polskasp. z o.o. + limited partnership	$217,397.69	aipolska.com

FAQ

Last updated: 2026-07-14